Sodium fluoride/sodium phosphate

Concentration (as F) 1,000 +/- 10 ug/mL Matrix: NaF, water

Concentration (as F) 1,000 +/- 10 ug/mL Matrix: NaF, water

Formula: NaF in H2O Harmonized Tariff Code:  3822.00

Formula: NaF in H2O Harmonized Tariff Code:  3822.00

An L-type calcium channel antagonist.

A potent, competitive inhibitor of HMG-CoA reductase (Ki = 0.3 nM).

A potent, competitive inhibitor of HMG-CoA reductase (Ki = 0.3 nM).

A Fluvastatin impurity and Fluvastatin ethyl analog. It is used as a pharmaceutical.

Fuzapladib sodium (IS-741 sodium) is a potent and orally active phospholipase A2 inhibitor. Fuzapladib sodium can block the adhesion of inflammatory cells to microvascular endothelial cells, inhibits the infiltration of neutrophils into the pancreas

Fuzapladib sodium (IS-741 sodium) is a potent and orally active phospholipase A2 inhibitor. Fuzapladib sodium can block the adhesion of inflammatory cells to microvascular endothelial cells, inhibits the infiltration of neutrophils into the pancreas

Fuzapladib sodium (IS-741 sodium) is a potent and orally active phospholipase A2 inhibitor. Fuzapladib sodium can block the adhesion of inflammatory cells to microvascular endothelial cells, inhibits the infiltration of neutrophils into the pancreas

Fuzapladib sodium (IS-741 sodium) is a potent and orally active phospholipase A2 inhibitor. Fuzapladib sodium can block the adhesion of inflammatory cells to microvascular endothelial cells, inhibits the infiltration of neutrophils into the pancreas